Reflex Testing

LabSolutions offers the latest in presumptive (qualitative) and confirmatory (quantitative) testing services. Our comprehensive menu includes more than 200 drugs and metabolites, allowing a multitude of different types of practices to monitor adherence and compliance.

The management of patients who suffer from chronic pain or other diagnoses requiring treatment with scheduled medications as part of their healthcare plan is evolving.

Many of the changes in the way we approach monitoring these patients over the last decade have been adopted to help combat a prescription drug abuse epidemic.

The death rate from prescription drug overdose has more than tripled over the last decade. Initiation of comprehensive protocols to assess adherence/compliance has become the standard of care in treating patients receiving scheduled medications.

As stated in the American Society of Interventional Pain Physicians Opioid Guidelines:

“Adherence monitoring is crucial to avoid abuse of the drugs and at the same time to encourage appropriate use, and involves the initiation of drug screening, pill counts, and patient care agreements, with the motto of ‘trust but VERIFY’.”

Our Toxicology testing options are customizable to allow physicians to individualize their orders according to patient needs. View our confirmation test menu here:

Confirmation Test Menu →

A sample confirmation report can be found here:

Confirmation Sample Report →

Why Test?

To protect physicians' patients and their practices.

As part of a larger Adherence Monitoring or Prescription Monitoring program.

To satisfy legal and regulatory requirements.

It is the standard of care for patients receiving scheduled medications in their course of treatment.

Learn about our other Toxicology testing options

Additional Information

Poor medication adherence takes the lives of over 125,000 Americans annually and costs the health care industry nearly $300 billion a year.

Drug-drug Interactions account for almost 4 percent of all emergency room visits.

Drug-drug Interactions cost the US healthcare system $136 billion annually.